Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueDepreciation & Amortization (IS)EBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsPreferred Shares IssuedProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

Coeptis Therapeutics Holdings (COEP) Accumulated Depreciation & Amortization (2021 - 2025)

Coeptis Therapeutics Holdings (COEP) has 5 years of Accumulated Depreciation & Amortization data on record, last reported at $15217.0 in Q3 2025.

  • For Q3 2025, Accumulated Depreciation & Amortization rose 4.48% year-over-year to $15217.0; the TTM value through Sep 2025 reached $15217.0, up 4.48%, while the annual FY2024 figure was $14777.0, 6.07% up from the prior year.
  • Accumulated Depreciation & Amortization reached $15217.0 in Q3 2025 per COEP's latest filing, up from $15070.0 in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $15217.0 in Q3 2025 and bottomed at $11311.0 in Q4 2021.
  • Average Accumulated Depreciation & Amortization over 5 years is $13917.3, with a median of $14142.0 recorded in 2024.
  • Peak YoY movement for Accumulated Depreciation & Amortization: increased 12.24% in 2022, then increased 4.48% in 2025.
  • A 5-year view of Accumulated Depreciation & Amortization shows it stood at $11311.0 in 2021, then increased by 12.24% to $12695.0 in 2022, then grew by 9.74% to $13931.0 in 2023, then increased by 6.07% to $14777.0 in 2024, then rose by 2.98% to $15217.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Accumulated Depreciation & Amortization were $15217.0 in Q3 2025, $15070.0 in Q2 2025, and $14924.0 in Q1 2025.